APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vitamin and Derivative

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vitamin and Derivative Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchVitamin and Derivative Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Vitamin and Derivative Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Vitamin and Derivative Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vitamin and Derivative Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Vitamin and Derivative Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Vitamin and Derivative market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vitamin and Derivative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vitamin and Derivative market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vitamin and Derivative market include Lonza Group, Pfizer, Bayer, ParkAcre Enterprises, Nutrilo, DuPont, DSM, BASF and Amway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vitamin and Derivative market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vitamin and Derivative and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vitamin and Derivative sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vitamin and Derivative market size, projected growth trends, production technologies, key applications, and end-use industries.

Vitamin and Derivative Segment by Company

Lonza Group

Pfizer

Bayer

ParkAcre Enterprises

Nutrilo

DuPont

DSM

BASF

Amway

Aland Nutraceutical

AIE Pharmaceuticals

Adisseo France S.A.A

Vitamin and Derivative Segment by Type

Vitamin and Derivative Capsules

Vitamin and Derivative Powder

Vitamin and Derivative Tablets

Vitamin and Derivative Segment by Application

Pharmaceuticals

Food and Beverages

Dietary Supplements

Personal Care

Others

Vitamin and Derivative Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Vitamin and Derivative status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vitamin and Derivative market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vitamin and Derivative significant trends, drivers, influence factors in global and regions.

6. To analyze Vitamin and Derivative competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin and Derivative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vitamin and Derivative and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin and Derivative.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vitamin and Derivative market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vitamin and Derivative industry.

Chapter 3: Detailed analysis of Vitamin and Derivative manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vitamin and Derivative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vitamin and Derivative in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vitamin and Derivative Industry Trends Table 2. Vitamin and Derivative Industry Drivers Table 3. Vitamin and Derivative Industry Opportunities and Challenges Table 4. Vitamin and Derivative Industry Restraints Table 5. Global Vitamin and Derivative Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vitamin and Derivative Revenue Share by Company (2021-2026) Table 7. Global Vitamin and Derivative Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Vitamin and Derivative Sales Volume Share by Company (2021-2026) Table 9. Global Vitamin and Derivative Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Vitamin and Derivative Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vitamin and Derivative Key Company Manufacturing Base & Headquarters Table 12. Global Vitamin and Derivative Company, Product Type & Application Table 13. Global Vitamin and Derivative Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vitamin and Derivative by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vitamin and Derivative Capsules Table 18. Significant Companies of Vitamin and Derivative Powder Table 19. Significant Companies of Vitamin and Derivative Tablets Table 20. Global Vitamin and Derivative Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Vitamin and Derivative Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Vitamin and Derivative Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Vitamin and Derivative Sales Volume Share by Type (2021-2026) Table 24. Global Vitamin and Derivative Sales Volume Share by Type (2027-2032) Table 25. Global Vitamin and Derivative Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vitamin and Derivative Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Vitamin and Derivative Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Vitamin and Derivative Sales Value Share by Type (2021-2026) Table 29. Global Vitamin and Derivative Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Pharmaceuticals Table 31. Significant Companies of Food and Beverages Table 32. Significant Companies of Dietary Supplements Table 33. Significant Companies of Personal Care Table 34. Significant Companies of Others Table 35. Global Vitamin and Derivative Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Vitamin and Derivative Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Vitamin and Derivative Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Vitamin and Derivative Sales Volume Share by Application (2021-2026) Table 39. Global Vitamin and Derivative Sales Volume Share by Application (2027-2032) Table 40. Global Vitamin and Derivative Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Vitamin and Derivative Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Vitamin and Derivative Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Vitamin and Derivative Sales Value Share by Application (2021-2026) Table 44. Global Vitamin and Derivative Sales Value Share by Application (2027-2032) Table 45. Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Vitamin and Derivative Sales by Region (2021-2026) & (K Units) Table 47. Global Vitamin and Derivative Sales Market Share by Region (2021-2026) Table 48. Global Vitamin and Derivative Sales by Region (2027-2032) & (K Units) Table 49. Global Vitamin and Derivative Sales Market Share by Region (2027-2032) Table 50. Global Vitamin and Derivative Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Vitamin and Derivative Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Vitamin and Derivative Sales Value Share by Region (2021-2026) Table 53. Global Vitamin and Derivative Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Vitamin and Derivative Sales Value Share by Region (2027-2032) Table 55. Global Vitamin and Derivative Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Vitamin and Derivative Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Vitamin and Derivative Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Vitamin and Derivative Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Vitamin and Derivative Sales by Country (2021-2026) & (K Units) Table 60. Global Vitamin and Derivative Sales Market Share by Country (2021-2026) Table 61. Global Vitamin and Derivative Sales by Country (2027-2032) & (K Units) Table 62. Global Vitamin and Derivative Sales Market Share by Country (2027-2032) Table 63. Global Vitamin and Derivative Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Vitamin and Derivative Sales Value Market Share by Country (2021-2026) Table 65. Global Vitamin and Derivative Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Vitamin and Derivative Sales Value Market Share by Country (2027-2032) Table 67. Lonza Group Company Information Table 68. Lonza Group Business Overview Table 69. Lonza Group Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Lonza Group Vitamin and Derivative Product Portfolio Table 71. Lonza Group Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Pfizer Vitamin and Derivative Product Portfolio Table 76. Pfizer Recent Development Table 77. Bayer Company Information Table 78. Bayer Business Overview Table 79. Bayer Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Bayer Vitamin and Derivative Product Portfolio Table 81. Bayer Recent Development Table 82. ParkAcre Enterprises Company Information Table 83. ParkAcre Enterprises Business Overview Table 84. ParkAcre Enterprises Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. ParkAcre Enterprises Vitamin and Derivative Product Portfolio Table 86. ParkAcre Enterprises Recent Development Table 87. Nutrilo Company Information Table 88. Nutrilo Business Overview Table 89. Nutrilo Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Nutrilo Vitamin and Derivative Product Portfolio Table 91. Nutrilo Recent Development Table 92. DuPont Company Information Table 93. DuPont Business Overview Table 94. DuPont Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. DuPont Vitamin and Derivative Product Portfolio Table 96. DuPont Recent Development Table 97. DSM Company Information Table 98. DSM Business Overview Table 99. DSM Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. DSM Vitamin and Derivative Product Portfolio Table 101. DSM Recent Development Table 102. BASF Company Information Table 103. BASF Business Overview Table 104. BASF Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. BASF Vitamin and Derivative Product Portfolio Table 106. BASF Recent Development Table 107. Amway Company Information Table 108. Amway Business Overview Table 109. Amway Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Amway Vitamin and Derivative Product Portfolio Table 111. Amway Recent Development Table 112. Aland Nutraceutical Company Information Table 113. Aland Nutraceutical Business Overview Table 114. Aland Nutraceutical Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Aland Nutraceutical Vitamin and Derivative Product Portfolio Table 116. Aland Nutraceutical Recent Development Table 117. AIE Pharmaceuticals Company Information Table 118. AIE Pharmaceuticals Business Overview Table 119. AIE Pharmaceuticals Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AIE Pharmaceuticals Vitamin and Derivative Product Portfolio Table 121. AIE Pharmaceuticals Recent Development Table 122. Adisseo France S.A.A Company Information Table 123. Adisseo France S.A.A Business Overview Table 124. Adisseo France S.A.A Vitamin and Derivative Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Adisseo France S.A.A Vitamin and Derivative Product Portfolio Table 126. Adisseo France S.A.A Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Vitamin and Derivative Distributors List Table 130. Vitamin and Derivative Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Vitamin and Derivative Product Image Figure 2. Global Vitamin and Derivative Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vitamin and Derivative Sales (2021-2032) & (K Units) Figure 5. Global Vitamin and Derivative Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Vitamin and Derivative Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vitamin and Derivative Capsules Image Figure 10. Vitamin and Derivative Powder Image Figure 11. Vitamin and Derivative Tablets Image Figure 12. Global Vitamin and Derivative Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Vitamin and Derivative Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Vitamin and Derivative Sales Volume Share by Type (2021-2032) Figure 15. Global Vitamin and Derivative Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Vitamin and Derivative Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Vitamin and Derivative Sales Value Share by Type (2021-2032) Figure 18. Pharmaceuticals Image Figure 19. Food and Beverages Image Figure 20. Dietary Supplements Image Figure 21. Personal Care Image Figure 22. Others Image Figure 23. Global Vitamin and Derivative Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Vitamin and Derivative Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Vitamin and Derivative Sales Volume Share by Application (2021-2032) Figure 26. Global Vitamin and Derivative Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Vitamin and Derivative Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Vitamin and Derivative Sales Value Share by Application (2021-2032) Figure 29. Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Vitamin and Derivative Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Vitamin and Derivative Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Vitamin and Derivative Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 34. North America Vitamin and Derivative Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Vitamin and Derivative Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Vitamin and Derivative Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 40. South America Vitamin and Derivative Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Vitamin and Derivative Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Vitamin and Derivative Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Vitamin and Derivative Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Vitamin and Derivative Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Vitamin and Derivative Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamin and Derivative Capsules
  • Vitamin and Derivative Powder
  • Vitamin and Derivative Tablets
Applications
  • Pharmaceuticals
  • Food and Beverages
  • Dietary Supplements
  • Personal Care
  • Others
Companies covered
  • Lonza Group
  • Pfizer
  • Bayer
  • ParkAcre Enterprises
  • Nutrilo
  • DuPont
  • DSM
  • BASF
  • Amway
  • Aland Nutraceutical
  • AIE Pharmaceuticals
  • Adisseo France S.A.A

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vitamin and Derivative Sales Value (2021-2032)
  4. 1.2.2 Global Vitamin and Derivative Sales Volume (2021-2032)
  5. 1.2.3 Global Vitamin and Derivative Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vitamin and Derivative Market Dynamics
  1. 2.1 Vitamin and Derivative Industry Trends
  2. 2.2 Vitamin and Derivative Industry Drivers
  3. 2.3 Vitamin and Derivative Industry Opportunities and Challenges
  4. 2.4 Vitamin and Derivative Industry Restraints
3 Vitamin and Derivative Market by Company
  1. 3.1 Global Vitamin and Derivative Company Revenue Ranking in 2025
  2. 3.2 Global Vitamin and Derivative Revenue by Company (2021-2026)
  3. 3.3 Global Vitamin and Derivative Sales Volume by Company (2021-2026)
  4. 3.4 Global Vitamin and Derivative Average Price by Company (2021-2026)
  5. 3.5 Global Vitamin and Derivative Company Ranking (2024-2026)
  6. 3.6 Global Vitamin and Derivative Company Manufacturing Base and Headquarters
  7. 3.7 Global Vitamin and Derivative Company Product Type and Application
  8. 3.8 Global Vitamin and Derivative Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vitamin and Derivative Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vitamin and Derivative Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vitamin and Derivative Market by Type
  1. 4.1 Vitamin and Derivative Type Introduction
  2. 4.1.1 Vitamin and Derivative Capsules
  3. 4.1.2 Vitamin and Derivative Powder
  4. 4.1.3 Vitamin and Derivative Tablets
  5. 4.2 Global Vitamin and Derivative Sales Volume by Type
  6. 4.2.1 Global Vitamin and Derivative Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vitamin and Derivative Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Vitamin and Derivative Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Vitamin and Derivative Sales Value by Type
  10. 4.3.1 Global Vitamin and Derivative Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vitamin and Derivative Sales Value by Type (2021-2032)
  12. 4.3.3 Global Vitamin and Derivative Sales Value Share by Type (2021-2032)
5 Vitamin and Derivative Market by Application
  1. 5.1 Vitamin and Derivative Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Food and Beverages
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Personal Care
  6. 5.1.5 Others
  7. 5.2 Global Vitamin and Derivative Sales Volume by Application
  8. 5.2.1 Global Vitamin and Derivative Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Vitamin and Derivative Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Vitamin and Derivative Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Vitamin and Derivative Sales Value by Application
  12. 5.3.1 Global Vitamin and Derivative Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Vitamin and Derivative Sales Value by Application (2021-2032)
  14. 5.3.3 Global Vitamin and Derivative Sales Value Share by Application (2021-2032)
6 Vitamin and Derivative Regional Sales and Value Analysis
  1. 6.1 Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vitamin and Derivative Sales by Region (2021-2032)
  3. 6.2.1 Global Vitamin and Derivative Sales by Region: 2021-2026
  4. 6.2.2 Global Vitamin and Derivative Sales by Region (2027-2032)
  5. 6.3 Global Vitamin and Derivative Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vitamin and Derivative Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vitamin and Derivative Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vitamin and Derivative Sales Value by Region (2027-2032)
  9. 6.5 Global Vitamin and Derivative Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vitamin and Derivative Sales Value (2021-2032)
  12. 6.6.2 North America Vitamin and Derivative Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vitamin and Derivative Sales Value (2021-2032)
  15. 6.7.2 Europe Vitamin and Derivative Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vitamin and Derivative Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vitamin and Derivative Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vitamin and Derivative Sales Value (2021-2032)
  21. 6.9.2 South America Vitamin and Derivative Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vitamin and Derivative Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vitamin and Derivative Sales Value Share by Country, 2025 VS 2032
7 Vitamin and Derivative Country-level Sales and Value Analysis
  1. 7.1 Global Vitamin and Derivative Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vitamin and Derivative Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vitamin and Derivative Sales by Country (2021-2032)
  4. 7.3.1 Global Vitamin and Derivative Sales by Country (2021-2026)
  5. 7.3.2 Global Vitamin and Derivative Sales by Country (2027-2032)
  6. 7.4 Global Vitamin and Derivative Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vitamin and Derivative Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vitamin and Derivative Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vitamin and Derivative Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vitamin and Derivative Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vitamin and Derivative Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza Group
  2. 8.1.1 Lonza Group Company Information
  3. 8.1.2 Lonza Group Business Overview
  4. 8.1.3 Lonza Group Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Group Vitamin and Derivative Product Portfolio
  6. 8.1.5 Lonza Group Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Vitamin and Derivative Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Vitamin and Derivative Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 ParkAcre Enterprises
  20. 8.4.1 ParkAcre Enterprises Company Information
  21. 8.4.2 ParkAcre Enterprises Business Overview
  22. 8.4.3 ParkAcre Enterprises Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ParkAcre Enterprises Vitamin and Derivative Product Portfolio
  24. 8.4.5 ParkAcre Enterprises Recent Developments
  25. 8.5 Nutrilo
  26. 8.5.1 Nutrilo Company Information
  27. 8.5.2 Nutrilo Business Overview
  28. 8.5.3 Nutrilo Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nutrilo Vitamin and Derivative Product Portfolio
  30. 8.5.5 Nutrilo Recent Developments
  31. 8.6 DuPont
  32. 8.6.1 DuPont Company Information
  33. 8.6.2 DuPont Business Overview
  34. 8.6.3 DuPont Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 DuPont Vitamin and Derivative Product Portfolio
  36. 8.6.5 DuPont Recent Developments
  37. 8.7 DSM
  38. 8.7.1 DSM Company Information
  39. 8.7.2 DSM Business Overview
  40. 8.7.3 DSM Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 DSM Vitamin and Derivative Product Portfolio
  42. 8.7.5 DSM Recent Developments
  43. 8.8 BASF
  44. 8.8.1 BASF Company Information
  45. 8.8.2 BASF Business Overview
  46. 8.8.3 BASF Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BASF Vitamin and Derivative Product Portfolio
  48. 8.8.5 BASF Recent Developments
  49. 8.9 Amway
  50. 8.9.1 Amway Company Information
  51. 8.9.2 Amway Business Overview
  52. 8.9.3 Amway Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Amway Vitamin and Derivative Product Portfolio
  54. 8.9.5 Amway Recent Developments
  55. 8.10 Aland Nutraceutical
  56. 8.10.1 Aland Nutraceutical Company Information
  57. 8.10.2 Aland Nutraceutical Business Overview
  58. 8.10.3 Aland Nutraceutical Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Aland Nutraceutical Vitamin and Derivative Product Portfolio
  60. 8.10.5 Aland Nutraceutical Recent Developments
  61. 8.11 AIE Pharmaceuticals
  62. 8.11.1 AIE Pharmaceuticals Company Information
  63. 8.11.2 AIE Pharmaceuticals Business Overview
  64. 8.11.3 AIE Pharmaceuticals Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AIE Pharmaceuticals Vitamin and Derivative Product Portfolio
  66. 8.11.5 AIE Pharmaceuticals Recent Developments
  67. 8.12 Adisseo France S.A.A
  68. 8.12.1 Adisseo France S.A.A Company Information
  69. 8.12.2 Adisseo France S.A.A Business Overview
  70. 8.12.3 Adisseo France S.A.A Vitamin and Derivative Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Adisseo France S.A.A Vitamin and Derivative Product Portfolio
  72. 8.12.5 Adisseo France S.A.A Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vitamin and Derivative Value Chain Analysis
  2. 9.1.1 Vitamin and Derivative Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vitamin and Derivative Sales Mode & Process
  6. 9.2 Vitamin and Derivative Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vitamin and Derivative Distributors
  9. 9.2.3 Vitamin and Derivative Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst